| 000 | 01608 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515132853.0 | ||
| 264 | 0 | _c20081113 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/nature07260 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoucek, Laura | |
| 245 | 0 | 0 |
_aModelling Myc inhibition as a cancer therapy. _h[electronic resource] |
| 260 |
_bNature _cOct 2008 |
||
| 300 |
_a679-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xcytology |
| 650 | 0 | 4 |
_aGenes, Dominant _xgenetics |
| 650 | 0 | 4 | _aGenes, ras |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aOncogene Protein p21(ras) _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSkin _xcytology |
| 650 | 0 | 4 |
_aTestis _xcytology |
| 650 | 0 | 4 |
_aTransgenes _xgenetics |
| 700 | 1 | _aWhitfield, Jonathan | |
| 700 | 1 | _aMartins, Carla P | |
| 700 | 1 | _aFinch, Andrew J | |
| 700 | 1 | _aMurphy, Daniel J | |
| 700 | 1 | _aSodir, Nicole M | |
| 700 | 1 | _aKarnezis, Anthony N | |
| 700 | 1 | _aSwigart, Lamorna Brown | |
| 700 | 1 | _aNasi, Sergio | |
| 700 | 1 | _aEvan, Gerard I | |
| 773 | 0 |
_tNature _gvol. 455 _gno. 7213 _gp. 679-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature07260 _zAvailable from publisher's website |
| 999 |
_c18188733 _d18188733 |
||